Stephen Jay Gould

Of all of Stephen Jay Gould's essays in Natural History, one stands out as my favorite—for egotistical reasons. "Hopeful Monsters" appeared in October 1980. German-American geneticist Richard Goldschmidt (1878-1958) coined the term hopeful monsters in 1940 to describe the occasional two-headed calf or five-legged frog mutant that might find another like itself, breed, and somehow produce a new species. Strict Darwinian gradualists ridiculed the idea, but Gould and Niles Eldridge's 1972 pun

Written byRicki Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Gould's hopeful monsters were the homeotic mutants of Drosophila melanogaster, notorious for their transformed body parts—wing to haltere, antenna to leg. Although the essay lacks the trademark baseball reference, it follows his typical talky style. An anecdote comparing homeotics to sideshow freaks opens the essay. Next comes the 'I couldn't have said it better' zinger: "Congenitally malformed bodies are nature's experiments, uncontrolled by intentional human art to be sure, but sources of insight nonetheless." Historical tidbits follow, introducing organisms mythical and otherwise with mismatched body parts, then a second nod to scientific thinking—it's not enough to observe nature; one must look experimentally for explanations and mechanisms.

Much of "Hopeful Monsters" deals with "a series of remarkable experiments" in the lab of Thomas Kaufman, at Indiana University, where noted geneticist Herman J. Muller once worked. Kaufman wasn't the only one spending every waking hour examining flies with legs on their heads. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies